Geller Matthew 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 23, 2011
Insider Transaction Report
Form 4
Geller Matthew
Director
Transactions
- Sale
Common Stock
2011-05-23$24.00/sh−1,900$45,600→ 17,700 total - Sale
Common Stock
2011-05-19$24.18/sh−400$9,671→ 29,600 total - Sale
Common Stock
2011-05-20$24.01/sh−10,000$240,054→ 19,600 total
Footnotes (2)
- [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.15 to $24.21. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.08. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.